We also show that systemic immune cells from patients with severe asthma release more IL-1β following a combination of pathogen (LPS)-induced priming and NLRP3 inflammasome activation compared to cells from patients with non-severe asthma (Fig. 1G, H). The gene discussed is IL1B; the disease is asthma.